Liquiritigenin, a licorice-derived flavanone, reduces dry eye pathology via dual anti-inflammatory and antioxidant action
LIQ shows potential as a therapeutic agent for DED through its dual anti-inflammatory and antioxidative actions, primarily through modulation of the AKR superfamily.
Authors
- Hong kyun Kim
- S K Kim
- Jeong Mun Choi
- Jeongho Kim (ORCID: https://orcid.org/0000-0003-2499-5877)
- Sinsung Kang
- Soojin Yi
- Chegyem Yae
Institutions
- Kyungpook National University Hospital (KR)
- Kyungpook National University (KR)
Publication Details
- Journal
- Taiwan Journal of Ophthalmology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.4103/tjo.tjo-d-25-00119
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00